
Pachydermoperiostosis (PDP), otherwise known as primary hypertrophic osteoarthropathy, is characterized by digital clubbing, pachydermia and subperiosteal new bone formation. Joint pain, polyarthritis, cutis verticis gyrata, seborrhea, and hyperhidrosis are frequently associated to this condition. We report a 17‐year‐old boy presented with pain and swelling of knees and ankles, and progressive thickening of skin face with seborrhea from about 4 years. At the admission he also showed digital clubbing of both hands and feet and palmoplantar hyperhidrosis. We hypothesized PDP and molecular analysis confirmed diagnosis showing a novel mutation in a homozygous state in the SLCO2A1 gene coding for prostaglandin transporter. He started therapy with hydroxychloroquine with a great improvement in joint pain and skin conditions. This is the first reported case of PDP who was successfully treated with hydroxychloroquine, with effects not only on arthralgia but also, surprisingly, on skin conditions.
Male, hydroxychloroquine, Adolescent, Osteoarthropathy, Primary Hypertrophic, Organic Anion Transporters, Bone and Bones, primary hypertrophic osteoarthropathy, Genetics, Humans, Genetic Predisposition to Disease, hydroxychloroquine; primary hypertrophic osteoarthropathy; prostaglandin transporter; SLCO2A1 gene; Genetics; Genetics (clinical), Genetics (clinical), Alleles, Genetic Association Studies, Skin, hydroxychloroquine; primary hypertrophic osteoarthropathy; prostaglandin transporter; SLCO2A1 gene; Adolescent; Alleles; Amino Acid Substitution; Bone and Bones; Exons; Humans; Hydroxychloroquine; Male; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; Radiography; Skin; Treatment Outcome; Genetic Association Studies; Genetic Predisposition to Disease; Homozygote; Mutation; Phenotype, SLCO2A1 gene, Homozygote, Exons, prostaglandin transporter, Radiography, Phenotype, Treatment Outcome, Amino Acid Substitution, Mutation, Hydroxychloroquine
Male, hydroxychloroquine, Adolescent, Osteoarthropathy, Primary Hypertrophic, Organic Anion Transporters, Bone and Bones, primary hypertrophic osteoarthropathy, Genetics, Humans, Genetic Predisposition to Disease, hydroxychloroquine; primary hypertrophic osteoarthropathy; prostaglandin transporter; SLCO2A1 gene; Genetics; Genetics (clinical), Genetics (clinical), Alleles, Genetic Association Studies, Skin, hydroxychloroquine; primary hypertrophic osteoarthropathy; prostaglandin transporter; SLCO2A1 gene; Adolescent; Alleles; Amino Acid Substitution; Bone and Bones; Exons; Humans; Hydroxychloroquine; Male; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; Radiography; Skin; Treatment Outcome; Genetic Association Studies; Genetic Predisposition to Disease; Homozygote; Mutation; Phenotype, SLCO2A1 gene, Homozygote, Exons, prostaglandin transporter, Radiography, Phenotype, Treatment Outcome, Amino Acid Substitution, Mutation, Hydroxychloroquine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
